Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| OCULIS | 3 | - | -1,45 % | ||
 | ALVOTECH | 3 | - | +8,04 % | |
 | EIMSKIP | 1 | 1 | - | |
| FESTI | - | 4 | - | |
| HEIMAR | - | 3 | - | |
| JBT MAREL | - | 2 | 0,00 % | ||
| ARION BANK | - | 1 | -1,28 % | ||
| ICELANDAIR GROUP HF | - | - | - | |
| HAGAR | - | - | - | |
| SKAGI | - | - | - |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Oculis Holding GAAP EPS of CHF -0.32 | 4 | Seeking Alpha | ||
| Mo | Oculis Holding AG: Oculis Reports Q3 2025 Financial Results and Provides Company Update | 3 | GlobeNewswire (USA) | ||
| Mo | Oculis Holding AG - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mo | Amaroq Ltd. - Change of ISIN | 83 | GlobeNewswire | With reference to announcements made by Amaroq Ltd. ("Issuer") on November 3, 2025 and October 21, 2025, the Icelandic Depository Receipts (IDRs) will be converted to Depositary Interests (DIs) as... ► Artikel lesen | |
| Mo | Alvotech: Britisches Gericht weist einstweilige Verfügung von Regeneron gegen Eylea-Biosimilar ab | 10 | Investing.com Deutsch | ||
| Mo | UK court rejects Regeneron's injunction against Alvotech's Eylea biosimilar | 3 | Investing.com | ||
| Mo | UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea (aflibercept) | 179 | GlobeNewswire (Europe) | REYKJAVIK, Iceland, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen | |
| Mo | Eimskipafelag Islands hf.: Transaction in relation to a share buy-back program | 4 | GlobeNewswire (USA) | ||
| Fr | Amaroq Ltd: Amaroq 52,986,036-share private placement | 5 | Stockwatch | ||
| Fr | Amaroq Ltd: Amaroq to release Q3 results Nov. 14 | 3 | Stockwatch | ||
| Fr | Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz | 7 | Pharmaceutical Business Review | ||
| Fr | Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz | 6 | Pharmaceutical Technology | ||
| Fr | Amaroq Ltd.: Notice of Results and Investor Presentation | 3 | GlobeNewswire (USA) | ||
| Do | Alvotech, Advanz Pharma Receive MHRA Marketing Authorizations for Gobivaz | 11 | Contract Pharma | ||
| Do | UK regulator approves Alvotech's golimumab biosimilar for immune diseases | 4 | Investing.com | ||
| Do | Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA | 232 | GlobeNewswire (Europe) | REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen | |
| Do | Icelandair Group hf.: Number of passengers increased by 14% in October | 309 | GlobeNewswire (Europe) | Icelandair carried a total of 464 thousand passengers in October, a 14% increase year-over-year. The growth was strong in the market to Iceland, where passenger numbers rose by 20% and in the market... ► Artikel lesen | |
| Mi | Kvika banki hf.: Financial Results for Q3 2025 | 206 | GlobeNewswire (Europe) | At a board meeting on 5 November 2025, the Board of Directors and the CEO approved the interim consolidated financial statements of the Kvika banki hf. ("Kvika" or "the bank") for the third quarter... ► Artikel lesen | |
| 04.11. | JBT Marel Corp - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 04.11. | Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update | 7 | GlobeNewswire (USA) |
1 2 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .